PCSK9 and coronary artery disorder: They disrupted the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene, leading to reduced blood cholesterol levels, lowering the risk of developing coronary heart disease (CHD) due to higher LDL cholesterol levels [13].